Christine Ocampo - Net Worth and Insider Trading
Christine Ocampo Net Worth
The estimated net worth of Christine Ocampo is at least $330 dollars as of 2024-09-20. Christine Ocampo is the See Remarks of Eledon Pharmaceuticals Inc and owns about 133 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $330. Details can be seen in Christine Ocampo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christine Ocampo has not made any transactions after 2017-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christine Ocampo
Christine Ocampo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christine Ocampo owns 2 companies in total, including Urovant Sciences Ltd (UROV) , and Eledon Pharmaceuticals Inc (ELDN) .
Click here to see the complete history of Christine Ocampo’s form 4 insider trades.
Insider Ownership Summary of Christine Ocampo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| UROV | Urovant Sciences Ltd | 2020-05-01 | PAO;CAO/Urovant Sciences & Inc |
| ELDN | Eledon Pharmaceuticals Inc | 2017-05-10 | See Remarks |
Christine Ocampo Latest Holdings Summary
Christine Ocampo currently owns a total of 1 stock. Christine Ocampo owns 133 shares of Eledon Pharmaceuticals Inc (ELDN) as of May 10, 2017, with a value of $330.
Latest Holdings of Christine Ocampo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2017-05-10 | 133 | 2.48 | 330 |
Holding Weightings of Christine Ocampo
Christine Ocampo Form 4 Trading Tracker
According to the SEC Form 4 filings, Christine Ocampo has made a total of 0 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years. The most-recent trade in Eledon Pharmaceuticals Inc is the acquisition of 62 shares on May 10, 2017, which cost Christine Ocampo around $100,000.
Insider Trading History of Christine Ocampo
- 1
Christine Ocampo Trading Performance
GuruFocus tracks the stock performance after each of Christine Ocampo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christine Ocampo is -29.82%. GuruFocus also compares Christine Ocampo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christine Ocampo within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christine Ocampo's insider trading performs compared to the benchmark.
Performance of Christine Ocampo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.66 | | | | | |
| Relative Return to S&P 500(%) | -4 | | | | | |
Christine Ocampo Ownership Network
Christine Ocampo Owned Company Details
What does Urovant Sciences Ltd do?
Who are the key executives at Urovant Sciences Ltd?
Christine Ocampo is the PAO;CAO/Urovant Sciences & Inc of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and GC/Urovant Sciences & Inc. Bryan E. Smith .
Urovant Sciences Ltd (UROV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Urovant Sciences Ltd Insider Transactions
Christine Ocampo Mailing Address
Above is the net worth, insider trading, and ownership report for Christine Ocampo. You might contact Christine Ocampo via mailing address: C/o Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine Ca 92617.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
